Winners of Best In Session at 8th EuCornea Congress
Colin Kerr
Published: Thursday, October 26, 2017
Delegates attending the Free Paper sessions at the 8th EuCornea Congress in Lisbon, Portugal
There was a very high standard of Free Papers at the 8th EuCornea Congress in Lisbon, Portugal. The following were the winners of the Best In Session.
Corneal Transplantation 1 - Mark Daniell (Australia)
Tissue-engineered Descemet's stripping endothelial keratoplasty, in vivo proof of concept in sheep
Infections and Inflammations - Joanne Goh ( United Kingdom)
Comparison of confocal microscopy, PCR and corneal culture for the early diagnosis of acanthamoeba keratitis
Keratoconus and Collagen Cross-Linking - Theo.G Seiler (Switzerland)
In vivo brillouin-shifts of cross-linked and uncross-linked corneas in keratoconus
Corneal Transplantation 2 - Elisa Marziali (Italy)
Descemet's stripping endothelial keratoplasty (DSEK) and Descemet's membrane endothelial keratoplasty (DMEK): A fellow eye comparison
Latest Articles
Glaucoma Treatment Under Pressure
New techniques and technologies add to surgeons’ difficult decisions
Outside the Box, Inside the Pipeline
Researchers are tackling glaucoma diagnosis and treatment from all sides.
The EHDS Is Ready for the Green Light
If proposal is approved, Europe could see better access to, and exchange and use of, health data.
ESCRS to Release Guidelines for Cataract and Refractive Surgery
Comprehensive approach to the safest and most effective modern surgery.
Barry Fellowship Opens Up ‘Whole New Field of Thought’
The 2022 recipient combines theoretical and practical to learn new treatments.
Digitalising the OR—Experience and Perspectives
Benefits include saving time and improving outcomes.
Dynamic Measures Needed for Quality of Vision
Functional visual acuity testing and straylight metering may better reflect real-world conditions.
What Is Stopping Digital OR Adoption?
Ophthalmologists know the benefits—now it’s time to construct the right plan.
Time to Move Beyond Monofocal IOLs?
European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.